患有脏移植拒绝患者肠道微生物群的明显变化
Vanessa Visconti1,2, Stefan Wirtz3, Mario Schiffer1,2
1Department of Nephrology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Transplantation direct
|February 21, 2024
概括
接受脏移植的接受者,有移植排斥,显示出不同的肠道微生物组概况. 识别这些微生物指纹可能会导致新的非侵入性生物标志物用于早期检测和拒绝的管理.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
背景情况:
- 移植拒绝是移植受体中移植损失的主要原因.
- 肠道微生物组与免疫系统的双向关系表明它对全移植结果的影响.
研究的目的:
- 鉴定移植患者的肠道微生物特征,有或没有移植排斥.
- 为了识别与异位移植排斥相关的队列特定的微生物指纹.
主要方法:
- 横截面病例控制研究设计.
- 16S核糖体RNA基因测序以分析肠道微生物组成.
- 严格的纳入和排除标准,以控制混因素.
主要成果:
- 排斥组和无排斥组之间肠道微生物种群丰度的显著差异.
- 在拒绝组中较低的α多样性和明显的β多样性.
- 特定的微生物种群和功能性基因丰度与慢性T细胞介导的排斥和炎症相关.
结论:
- 一个明显的肠道微生物指纹与脏异位移植排斥有关.
- 这种微生物特征可能成为未来移植拒绝的潜在非侵入性生物标志物.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...


